// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A Nurse Led Service Providing Safe and Effective Peri-Operative Anticoagulation

P. Priest - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

A Performance Evaluation of Chemiluminescent-Enzyme Immunoassays on a Routine Coagulation Analyser

C. Gardiner - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Disseminated intravascular coagulation

N/A

A Randomized, Multicenter, Open-label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Persons with Hemophilia A in the Asia-Pacific region (HAVEN 5)

S. Wang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

A Single Centre Experience on the Use of Direct Oral Anticoagulants in People with Human Immunodeficiency Virus (HIV)

S. Patel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accuracy of Commercial Universal Calibrators for Measurement of Heparin and Low Molecular Weight Heparin

J. Hogwood - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Activity Measurement of Factor IX Padua against the 4th International Standard for FIX, Plasma

E. Gray - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute Deep Vein Thrombosis Is Associated with Increased Platelet Thrombin Generation and Increased Procoagulant Oxidised Phosphatidylethanolamine

S.G. Obaji - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

Phosphatidylserine

Advancing the Understanding and Significance of Genetic Testing Results in Hemostasis/Thrombosis

K. Lee - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hereditary hemorrhagic telangiectasia

N/A

Adverse Event Reporting in Haemophilia A Patients with and without Inhibitors Treated with Emicizumab: A Report from the Co-morbidity Working Party of the UK Haemophilia Centres Doctors´ Organisation (UKHCDO)

C. Wall - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

An Artificial Lipid Membrane Platform as an Approach to Study CLEC-2 Receptor Clustering

M.A. Sowa - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Assessment of the Cost-Effectiveness of Whole-Leg Ultrasound Scans Compared to Proximal Leg Vein Ultrasound Scans in the Diagnosis of Acute Deep Vein Thrombosis

G. Bertone - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

An Audit Examining Information Provided to Patients Regarding Venous Thromboembolism (VTE) at Discharge

K. Karia - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

An Evaluation of Treatment Monitoring in Patients with VWD Using a Chemiluminescent (VWF:GP1bR) Assay Compared to a Lyophilised Platelet Assay with Ristocetin (VWF:RCo)

A. Riddell - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alphanate

An Insight into Clinical Outcomes in Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study

F. Nissen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

An observational Study of INR Control and Bleeding Events, According to European Society of Cardiology (ESC) Guidelines, in Non-valvular Atrial Fibrillation (NVAF) Stratified by Male and Female Sex

D. Harris - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-valvular atrial fibrillation

Warfarin

Anti-complement Effect of Heparin in Stimulated Whole Blood

J. Hogwood - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Anticoagulant Activity in Unclassified Bleeding Disorders

D. White - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Thrombomodulin alfa

Anticoagulation Control with the Point-of-Care INR: A Retrospective Pre-/Post-analysis

N. Riva - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

Apixaban versus Heparin/Warfarin Treatment in Pulmonary Embolism: Results from the UK Apixaban Length-of-Stay Pulmonary Embolism – Hospital Admissions Study (ALPHA-PE)

R. Alikhan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

apixaban

Are Therapeutic Immunoglobulins Free from Factor XIa?

H. Wilmot - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

IVIG

Copyright © 2026. QuantiNova All rights reserved